Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
AbbVie plans to build out its presence in obesity market - 2CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth
- 3Share your number one city visit transport that leaves a mark on the world wake up!
- 4New movies to watch this weekend: See 'Predator: Badlands' in theaters, rent 'Black Phone 2,' stream Guillermo del Toro's 'Frankenstein' on Netflix
- 5Moon rocket and weather are on NASA's side for the first astronaut launch in decades
- Olivia Rodrigo announces 3rd album, 'You Seem Pretty Sad for a Girl So in Love,' set to debut in June
- Administrative building in Sharjah region targeted by Iranian drone, UAE authorities announce
- Which Breakfast Enraptures Your Taste Buds? Vote
- Sheinelle Jones will cohost fourth hour of 'Today' with Jenna Bush Hager: Here's what to know about her
- EU Commission slams Israel's death penalty law for Palestinians
- At least 490 protesters killed in Iran, activists say
- Australia’s post-Bondi crackdown accused of targeting pro-Palestinian voices
- 5 Advancement Developments in Biotechnology
- Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture
